Evidence map›Paper›PMID 34106394›Full record

ArticleNeurochemical research2021

Neuroprotective Effects of Sodium Butyrate through Suppressing Neuroinflammation and Modulating Antioxidant Enzymes.

Al Borhan Bayazid, Young Ah Jang, Yu Mi Kim, Jae Gon Kim, Beong Ou Lim

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Butyrate Is Associated with the Antidepressant Effects ofInternational journal of molecular sciences · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Exploring the role of infectious pathogens in Alzheimer's disease neuroinflammation.Frontiers in cellular and infection microbiology · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Al Borhan BayazidDepartment of Integrated Biosciences, Graduate School of Konkuk University, Chungju, 27478, Korea.
Young Ah JangConvergence Research Center for Smart Healthcare, R&DB Foundation of Kyungsung University, Busan, Korea.
Yu Mi KimBio-Nano Technology Co, Daegu, Korea.
Jae Gon KimBK21 FOUR, GLOCAL Education Program for Nutraceutical and Biopharmaceutical Research, Konkuk University, Chungju, 27478, Korea.
Beong Ou LimDepartment of Integrated Biosciences, Graduate School of Konkuk University, Chungju, 27478, Korea. beongou@kku.ac.kr.ORCID http://orcid.org/0000-0002-9618-5956
Konkuk University · KRDaegu TechnoPark · KRKyungsung University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discovery of effective therapeutic agents against neurodegenerative diseases (NDDs) remains challenging. Neurotoxicity, inflammations, and oxidative stress are associating factors of NDDs. Sodium butyrate (NaB) is a short-chain fatty acid found in diet and produced in the gut that reportedly protects cancer, inflammation, obesity and so on. Previously, SH-SY5Y cells were studied as in vitro models of cerebral diseases. We have investigated the neuroprotective effects of NaB in SH-SY5Y cells stimulated with TNF-α. The expression of inflammatory mediators, including iNOS, COX-2, and mitogen-activated protein kinases (MAPK) and the apoptotic regulators, including P-53, Bcl-2 associated X (BAX) Protein, and caspase-3 were analyzed by western blot analysis. The anti-apoptotic gene Bcl-2 and the pro-apoptotic gene BAX translocation were also investigated. Our results showed that NaB attenuated cell death and inhibited the NO production and decreased the expression of iNOS and COX-2 in TNF-α-stimulated SH-SY5Y cells. NaB notably ameliorated apoptotic regulatory proteins p-53, Caspase-3 and caspase-1 level, and reversed phosphorylation of extracellular signal-regulated kinases and p-38 proteins. NaB ameliorated Glucocorticoid receptor and NLRP3 inflammasome expressions. NaB also suppressed the BAX nuclear translocation and modulated Nrf-2, HO-1 and MnSOD expression in neuroblastoma cells. In addition, NaB substantially reversed the reactive oxygen species in H

Indexed as

Apoptosis Regulatory ProteinsButyric AcidCell Line, TumorCell SurvivalCyclooxygenase 2Glutathione PeroxidaseGlutathione Peroxidase GPX1HumansInflammationNeuroprotective AgentsNitric OxideNitric Oxide Synthase Type IISuperoxide DismutaseTumor Necrosis Factor-alphaApoptosis Regulatory ProteinsButyric AcidCyclooxygenase 2Glutathione PeroxidaseGlutathione Peroxidase GPX1GPX1 protein, humanNeuroprotective AgentsNitric OxideNitric Oxide Synthase Type IINOS2 protein, humanSuperoxide DismutaseTumor Necrosis Factor-alphaGlucocorticoid receptorNeurodegenerative diseasesNLRP3NutraceuticalsSH-SY5Y cellsSodium butyrate

Identifiers

PMID34106394
OpenAlexW3168612969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.